Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

METHODS Special Issue: A Universal Protocol for Attaching Any Peptide to Dyed Magnetic Beads

A new technique eliminates the use of monoclonal antibodies and is robust enough for field use

In the publication, authors Matthew Coppock and Dimitra Stratis-Cullum describe efforts to attach peptides to magnetic beads for potential use in the field. Their studies were performed using the Luminex® 200™ System since “Luminex instruments are of high interest because they can be found in some mobile lab settings and are more sensitive compared to other similar devices.”

Continue Reading >

xMAP® Connect



xMAP® Connect is structured to grow your network and to enable you to discover the endless applications of xMAP Technology. During the program, you will hear from multiplex experts about cutting-edge methods development and innovative projects from the research and clinical spaces, as well as connect with fellow researchers, Luminex partners, and Luminex specialists onsite.

Watch more videos >

Luminex on Twitter

Perhaps the sweetest title of #xMAPConnect Amsterdam talks so far: "How Sweet Can Multiplexing Be? Profiling Cancer…
h J R
RT @Luminex: The way we make our products matters. Think you can help us raise the bar? We're looking for a master of #manufacturing who ca…
h J R
RT @Luminex: We are excited to announce the FDA clearance of our ARIES(R) MRSA Assay! This addition to our HAI portfolio will aid in the pr…
h J R

Latest News

October 1
Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay

September 26
Luminex Corporation to Present at the Cantor Global Healthcare Conference on
October 2, 2019

September 3
Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

July 31
Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend

July 11
Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019


October 2-6
Washington, D.C.

xMAP® Connect San Diego
October 3
San Diego, CA